1887

Abstract

Purpose. Despite WHO recommendations, there is currently no national screening and eradication policy for the detection of methicillin-sensitive Staphylococcus aureus (MSSA) in the UK prior to elective orthopaedic surgery. This study aimed to evaluate the effectiveness of current standard methicillin-resistant S. aureus (MRSA) eradication therapies in the context of S. aureus (both MRSA and MSSA) decolonization in an elective orthopaedic population.

Methodology. A total of 100 patients awaiting joint replacement surgery who were positive for S. aureus on PCR nasal screening underwent the current standard MRSA pre-operative decolonization regimen for 5 days. Prior to commencement of the eradication therapy, swabs of the anterior nares, throat and perineum were taken for culture. Further culture swabs were taken at 48–96 h following treatment, at hospital admission for surgery and at hospital discharge. Following the completion of treatment, patients were asked to provide feedback on their experience using Likert rating scales. The primary outcome of this study was S. aureus clearance 48–96 h following eradication treatment.

Results/Key Findings. Clearance of S. aureus 48–96 h following treatment was 94 % anterior nares, 66 % throat and 88 % groin. Mean completion with nasal mupirocin was 98 %. There was no statistically significant recolonization effect between the end of the eradication treatment period and the day of surgery (P>0.05) at a median time of 10 days.

Conclusion. Current MRSA decolonisation regimens are well tolerated and effective for MSSA decolonization for the anterior nares and groin. The decolonization effect is preserved for at least 10 days following treatment.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000731
2018-04-19
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/6/893.html?itemId=/content/journal/jmm/10.1099/jmm.0.000731&mimeType=html&fmt=ahah

References

  1. Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23: 183– 189 [CrossRef] [PubMed]
    [Google Scholar]
  2. British Orthopaedic Association Getting It Right First Time. 2015; Available from www.boa.ac.uk/pro-practice/getting-it-right-first-time/
  3. Public Health England Surveillance of surgical site infections in NHS hospitals in England. 2016; Available from www.gov.uk/government/uploads/system/uploads/attachment_data/file/577418/Surgical_site_infections_NHS_hospitals_2015_to_2016.pdf
  4. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344: 11– 16 [CrossRef] [PubMed]
    [Google Scholar]
  5. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364: 703– 705 [CrossRef] [PubMed]
    [Google Scholar]
  6. Levy PY, Ollivier M, Drancourt M, Raoult D, Argenson JN. Relation between nasal carriage of Staphylococcus aureus and surgical site infection in orthopedic surgery: the role of nasal contamination. A systematic literature review and meta-analysis. Orthop Traumatol Surg Res 2013; 99: 645– 651 [CrossRef] [PubMed]
    [Google Scholar]
  7. Kalra L, Camacho F, Whitener CJ, Du P, Miller M et al. Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. Am J Infect Control 2013; 41: 1253– 1257 [CrossRef] [PubMed]
    [Google Scholar]
  8. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009; 48: 922– 930 [CrossRef] [PubMed]
    [Google Scholar]
  9. den Heijer CD, van Bijnen EM, Paget WJ, Pringle M, Goossens H et al. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis 2013; 13: 409– 415 [CrossRef] [PubMed]
    [Google Scholar]
  10. Tsang STJ, McHugh MP, Guerendiain D, Gwynne PJ, Boyd J et al. Underestimation of Staphylococcus aureus (MRSA and MSSA) carriage associated with standard culturing techniques: one third of carriers missed. Bone Joint Res 2018; 7: 79– 84 [CrossRef] [PubMed]
    [Google Scholar]
  11. Berthelot P, Grattard F, Cazorla C, Passot JP, Fayard JP et al. Is nasal carriage of Staphylococcus aureus the main acquisition pathway for surgical-site infection in orthopaedic surgery?. Eur J Clin Microbiol Infect Dis 2010; 29: 373– 382 [CrossRef] [PubMed]
    [Google Scholar]
  12. Weiser MC, Moucha CS. The current state of screening and decolonization for the prevention of Staphylococcus aureus surgical site infection after total hip and knee arthroplasty. J Bone Joint Surg Am 2015; 97: 1449– 1458 [CrossRef] [PubMed]
    [Google Scholar]
  13. Dancer SJ, Christison F, Eslami A, Gregori A, Miller R et al. Is it worth screening elective orthopaedic patients for carriage of Staphylococcus aureus? A part-retrospective case-control study in a Scottish hospital. BMJ Open 2016; 6: e011642 011647 [CrossRef] [PubMed]
    [Google Scholar]
  14. Allegranzi B, Bischoff P, de Jonge S, Kubilay NZ, Zayed B et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis 2016; 16: e276 e287 [CrossRef] [PubMed]
    [Google Scholar]
  15. Scottish Arthoplasty Project Scottish arthroplasty project biennial report 2016. 2016; Available from www.arthro.scot.nhs.uk/docs/2016-08-09-SAP-Report.pdf?1
  16. National Joint Registry 13th annual report national joint registry for England, Wales, Northern Ireland and the isle of man. 2016; Available from www.njrcentre.org.uk/njrcentre/Reports,PublicationsandMinutes/tabid/85/Default.aspx
  17. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9– 17 [CrossRef] [PubMed]
    [Google Scholar]
  18. Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res 2013; 471: 2383– 2399 [CrossRef] [PubMed]
    [Google Scholar]
  19. Rao N, Cannella B, Crossett LS, Yates AJ, McGough R. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008; 466: 1343– 1348 [CrossRef] [PubMed]
    [Google Scholar]
  20. Coskun D, Aytac J. Decrease in Staphylococcus aureus surgical-site infection rates after orthopaedic surgery after intranasal mupirocin ointment. J Hosp Infect 2004; 58: 90– 91 [CrossRef] [PubMed]
    [Google Scholar]
  21. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP et al. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008; 466: 1349– 1355 [CrossRef] [PubMed]
    [Google Scholar]
  22. Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg Br 2012; 94: 619-23 [CrossRef] [PubMed]
    [Google Scholar]
  23. Ritchie K, Craig J, Eastgate J, Foster L, Kohli H et al. The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA). National Health Improvement Scotland. 2007; Available from www.healthcareimprovementscotland.org/previous_resources/hta_report/hta_9.aspx
  24. Bradley SF. MRSA colonisation (eradicating colonisation in people without active invasive infection). BMJ Clin Evid 2015; 2015: pii: 0923
    [Google Scholar]
  25. Chen AF, Heyl AE, Xu PZ, Rao N, Klatt BA. Preoperative decolonization effective at reducing staphylococcal colonization in total joint arthroplasty patients. J Arthroplasty 2013; 28: 18– 20 [CrossRef] [PubMed]
    [Google Scholar]
  26. Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis 1993; 17: 466– 474 [CrossRef] [PubMed]
    [Google Scholar]
  27. Maslow J, Hutzler L, Cuff G, Rosenberg A, Phillips M et al. Patient experience with mupirocin or povidone-iodine nasal decolonization. Orthopedics 2014; 37: e576 e581 [CrossRef] [PubMed]
    [Google Scholar]
  28. Walker ES, Vasquez JE, Dula R, Bullock H, Sarubbi FA. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?. Infect Control Hosp Epidemiol 2003; 24: 342– 346 [CrossRef] [PubMed]
    [Google Scholar]
  29. Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 2013; 85: 249– 256 [CrossRef] [PubMed]
    [Google Scholar]
  30. Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR et al. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother 2012; 56: 1324– 1330 [CrossRef] [PubMed]
    [Google Scholar]
  31. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control 1999; 27: 97– 132 [PubMed] [Crossref]
    [Google Scholar]
  32. Edmiston CE, Seabrook GR, Johnson CP, Paulson DS, Beausoleil CM. Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control 2007; 35: 89– 96 [CrossRef] [PubMed]
    [Google Scholar]
  33. Kapadia BH, Johnson AJ, Daley JA, Issa K, Mont MA. Pre-admission cutaneous chlorhexidine preparation reduces surgical site infections in total hip arthroplasty. J Arthroplasty 2013; 28: 490– 493 [CrossRef] [PubMed]
    [Google Scholar]
  34. Johnson AJ, Kapadia BH, Daley JA, Molina CB, Mont MA. Chlorhexidine reduces infections in knee arthroplasty. J Knee Surg 2013; 26: 213– 218 [CrossRef] [PubMed]
    [Google Scholar]
  35. Farber NJ, Chen AF, Bartsch SM, Feigel JL, Klatt BA. No infection reduction using chlorhexidine wipes in total joint arthroplasty. Clin Orthop Relat Res 2013; 471: 3120– 3125 [CrossRef] [PubMed]
    [Google Scholar]
  36. Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC Infect Dis 2014; 14: 177 [CrossRef] [PubMed]
    [Google Scholar]
  37. Gehrke T, Parvizi J. Proceedings of the international consensus meeting on periprosthetic joint infection. 2013; Available from www.efort.org/wp-content/uploads/2013/10/Philadelphia_Consensus.pdf
  38. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Cochrane Wounds Group Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. In van Rijen M. (editor) Cochrane Database of Systematic Reviewsvol. 4 Chichester, UK: John Wiley & Sons, Ltd; 2008; pp. CD006216 [CrossRef]
    [Google Scholar]
  39. Hudson IR. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994; 27: 81– 98 [CrossRef] [PubMed]
    [Google Scholar]
  40. Caffrey AR, Quilliam BJ, Laplante KL. Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus. J Hosp Infect 2010; 76: 206– 210 [CrossRef] [PubMed]
    [Google Scholar]
  41. Lee AS, Macedo-Vinas M, François P, Renzi G, Vernaz N et al. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J Hosp Infect 2011; 77: 360– 362 [CrossRef] [PubMed]
    [Google Scholar]
  42. Johnson AJ, Daley JA, Zywiel MG, Delanois RE, Mont MA. Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty 2010; 25: 98– 102 [CrossRef] [PubMed]
    [Google Scholar]
  43. [Google Scholar]
  44. Roethlisberger F, Dickson W. Management and the Worker Cambridge, Massachecchets: Harvard University Press; 1939
    [Google Scholar]
  45. Llewelyn MJ, Fitzpatrick JM, Darwin E, SarahTonkin-Crine, Gorton C et al. The antibiotic course has had its day. BMJ 2017; 358: j3418 [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000731
Loading
/content/journal/jmm/10.1099/jmm.0.000731
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error